Mark O'Donnell is currently the Vice President of Regulatory Affairs for the Medical Segment at BD, a role they have held since 2018. Prior to this, Mark served as the Vice President of Regulatory Affairs at Medtronic Diabetes from 2011 to 2018, and as the Sr. Director of Regulatory Affairs at Allergan from 2008 to 2011. Earlier in their career, Mark held the position of Director of Regulatory Affairs at Biosense Webster and Johnson & Johnson, contributing significantly to regulatory strategies and product registrations. Mark completed their education at the University of Michigan from 1986 to 1990.
This person is not in any teams
This person is not in any offices